TAK-771-4002: Evaluating the Safety of GAMMAGARD LIQUID for the Treatment of Patients With Chronic Inflammatory Demyelinating PolyradiculoneuropathyFirst published 11/03/2022 Last updated 19/02/2024 EU PAS number: EUPAS46101StudyFinalisedDownload as PDF
RTI Health Solutions (RTI-HS)FranceSpainSwedenUnited KingdomUnited Kingdom (Northern Ireland)United States First published: 21/04/2010Last updated 19/02/2024 InstitutionNot-for-profitENCePP partner